Carnostatine Hydrochloride is a peptide-like inhibitor scaffold studied for its interactions with carboxypeptidases in biochemical assays. Functional groups mimic substrate termini while resisting full hydrolysis. Researchers analyze inhibition mechanisms, binding geometry, and pH dependence. Applications include enzyme-mechanism elucidation, inhibitor-screening platforms, and structure-activity evaluation.
CAT No: R2757
Synonyms/Alias:Carnostatine (hydrochloride); Carnostatine hydrochloride; SAN9812 (hydrochloride); AKOS040732716; HY-112431A; MS-24186; CS-0103026; G17254; (2S)-2-[[(2S)-4-amino-2-hydroxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid; hydrochloride
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.